Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Plumb

Showing results (171-180 of 210) with videos related to

Pageof 21
Sort By:
Biochimica Et Biophysica Acta|January 20, 1998
Inhibition of phospholipid signalling and proliferation of Swiss 3T3 cells by the wortmannin analogue demethoxyviridinM J Cross, M N Hodgkin, J A Plumb, et al.
Free Radical Research|July 1, 1996
Are whole extracts and purified glucosinolates from cruciferous vegetables antioxidants?G W Plumb, N Lambert, S J Chambers, et al.
AJR. American Journal of Roentgenology|November 13, 2019
Traditional Serrated Adenomas on CT Colonography: International Multicenter Experience With This Rare Colorectal NeoplasmJeannine A Ruby, Laura Pusceddu, Andrew A Plumb, et al.
The Journal of Biological Chemistry|January 6, 2010
GADD45beta enhances Col10a1 transcription via the MTK1/MKK3/6/p38 axis and activation of C/EBPbeta-TAD4 in terminally differentiating chondrocytesKaneyuki Tsuchimochi, Miguel Otero, Cecilia L Dragomir, et al.
Journal of the American Chemical Society|March 16, 2010
Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatinSarah D Brown, Paola Nativo, Jo-Ann Smith, et al.
Cancer Chemotherapy and Pharmacology|August 14, 2010
Pharmacokinetic and pharmacodynamic properties of an oral formulation of the histone deacetylase inhibitor Belinostat (PXD101)N L Steele, J A Plumb, L Vidal, et al.
Oncogene|January 25, 2003
Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductaseAlan E Bilsland, Claire J Anderson, Aileen J Fletcher-Monaghan, et al.
Oncogene|January 18, 2012
Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profilingC Zeller, W Dai, N L Steele, et al.
European Cells & Materials|February 26, 2011
Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritisMary B Goldring, Miguel Otero, Darren A Plumb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
A phase 1 pharmacokinetic and pharmacodynamic study of the histone deacetylase inhibitor belinostat in patients with advanced solid tumorsNicola L Steele, Jane A Plumb, Laura Vidal, et al.
Pageof 21

Showing results (171-180 of 210) with videos related to

Sort By:
Pageof 21
Biochimica Et Biophysica Acta|January 20, 1998
Inhibition of phospholipid signalling and proliferation of Swiss 3T3 cells by the wortmannin analogue demethoxyviridinM J Cross, M N Hodgkin, J A Plumb, et al.
Free Radical Research|July 1, 1996
Are whole extracts and purified glucosinolates from cruciferous vegetables antioxidants?G W Plumb, N Lambert, S J Chambers, et al.
AJR. American Journal of Roentgenology|November 13, 2019
Traditional Serrated Adenomas on CT Colonography: International Multicenter Experience With This Rare Colorectal NeoplasmJeannine A Ruby, Laura Pusceddu, Andrew A Plumb, et al.
The Journal of Biological Chemistry|January 6, 2010
GADD45beta enhances Col10a1 transcription via the MTK1/MKK3/6/p38 axis and activation of C/EBPbeta-TAD4 in terminally differentiating chondrocytesKaneyuki Tsuchimochi, Miguel Otero, Cecilia L Dragomir, et al.
Journal of the American Chemical Society|March 16, 2010
Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatinSarah D Brown, Paola Nativo, Jo-Ann Smith, et al.
Cancer Chemotherapy and Pharmacology|August 14, 2010
Pharmacokinetic and pharmacodynamic properties of an oral formulation of the histone deacetylase inhibitor Belinostat (PXD101)N L Steele, J A Plumb, L Vidal, et al.
Oncogene|January 25, 2003
Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductaseAlan E Bilsland, Claire J Anderson, Aileen J Fletcher-Monaghan, et al.
Oncogene|January 18, 2012
Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profilingC Zeller, W Dai, N L Steele, et al.
European Cells & Materials|February 26, 2011
Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritisMary B Goldring, Miguel Otero, Darren A Plumb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
A phase 1 pharmacokinetic and pharmacodynamic study of the histone deacetylase inhibitor belinostat in patients with advanced solid tumorsNicola L Steele, Jane A Plumb, Laura Vidal, et al.
Pageof 21